These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1708953

  • 21. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 22. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Dec 15; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of interferons in the treatment of solid tumors.
    Wadler S.
    Cancer; 1992 Aug 15; 70(4 Suppl):949-58. PubMed ID: 1379117
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K, Tsukamoto T.
    Hinyokika Kiyo; 1989 May 15; 35(5):737-47. PubMed ID: 2801371
    [Abstract] [Full Text] [Related]

  • 27. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A.
    J Natl Cancer Inst; 1982 Apr 15; 68(4):555-62. PubMed ID: 6175786
    [Abstract] [Full Text] [Related]

  • 28. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
    Cristoforoni PM, Lotzová E, Cook KR, Chuang LT, Morris M, Grossi CE, Wharton JT.
    Gynecol Oncol; 1994 Mar 15; 52(3):365-72. PubMed ID: 7512522
    [Abstract] [Full Text] [Related]

  • 29. [Update on the use of interferons in clinical practice].
    Lauta VM.
    Clin Ter; 1995 Mar 15; 146(6-7):393-448. PubMed ID: 7586995
    [Abstract] [Full Text] [Related]

  • 30. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ, Borden EC, Kalvakolanu DV.
    Clin Cancer Res; 1997 Jun 15; 3(6):931-7. PubMed ID: 9815768
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI, Viadro MM, Leĭkin IuD, Kuznetsov VP, Trakhtenberg AKh.
    Eksp Onkol; 1986 Jun 15; 8(3):44-6. PubMed ID: 2424715
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
    Weiner LM, Padavic-Shaller K, Kitson J, Watts P, Krigel RL, Litwin S.
    Cancer Res; 1991 Aug 01; 51(15):3910-8. PubMed ID: 1906779
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
    Ferrantini M, Capone I, Belardelli F.
    Biochimie; 2007 Aug 01; 89(6-7):884-93. PubMed ID: 17532550
    [Abstract] [Full Text] [Related]

  • 37. [Bases on timing of combined modality of chemotherapy and immunotherapy].
    Ogura T.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 1):1414-20. PubMed ID: 1697153
    [Abstract] [Full Text] [Related]

  • 38. Role of vincristine in immunochemotherapy of leukemia in mouse or human models.
    Prete SP, De Filippi R, Silvi E, Bartocci A, Giuliani A.
    Immunopharmacol Immunotoxicol; 1990 Aug 01; 12(1):135-57. PubMed ID: 2351791
    [Abstract] [Full Text] [Related]

  • 39. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S, Schwartz EL.
    Cancer Res; 1990 Jun 15; 50(12):3473-86. PubMed ID: 1692761
    [Abstract] [Full Text] [Related]

  • 40. Interferons in renal-cell carcinoma: status and prospects.
    De Mulder PH, Debruyne FM, Beniers AJ.
    Prog Clin Biol Res; 1990 Jun 15; 348():49-59. PubMed ID: 1696737
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.